Patents by Inventor Michael Block

Michael Block has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060041128
    Abstract: This invention relates to novel compounds having the structural formula (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment or prophylaxis of cancer.
    Type: Application
    Filed: August 18, 2005
    Publication date: February 23, 2006
    Applicant: AstraZeneca AB
    Inventors: Brian Aquila, Michael Block, Audrey Davies, Jayachandran Ezhuthachan, Timothy Pontz, Daniel Russell, Maria-Elena Theoclitou, XiaoLan Zheng
  • Publication number: 20050209233
    Abstract: Compounds of formula (I): wherein: X is a group of formula (B): ?and R1, R2, R4, n, x, y and z are as defined within are described. Processes for their preparation and their use in the treatment of disorders mediated by the neuropeptide Y5 receptor in a warm-blooded animal, such as a human being, are also described.
    Type: Application
    Filed: May 12, 2005
    Publication date: September 22, 2005
    Applicant: AstraZeneca AB
    Inventors: Michael Block, Kevin Foote
  • Publication number: 20050080106
    Abstract: The invention relates to the use of a compound of Formula (I) or a salt, solvate or prodrug thereof, wherein R1, R2, R3, n and m are as described in the specification, in the preparation of a medicament for the treatment or prevention of a disease condition mediated through glucokinase (GLK), such as type 2 diabetes. The invention also relates to a novel group of compounds of Formula (I) and to methods for preparing compounds of Formula (I).
    Type: Application
    Filed: August 15, 2002
    Publication date: April 14, 2005
    Applicant: AstraZeneca AB
    Inventors: Scott Boyd, Peter Caulkett, Rodney Hargreaves, Suzanne Bowker, Roger James, Clifford Jones, Darren McKerrecher, Michael Block, Craig Johnstone
  • Publication number: 20050065157
    Abstract: The use of a compound of formula (I) in the manufacture of a medicament for the treatment, in a warm-blooded animal, of disorders mediated by the neuropeptide Y5 receptor: wherein: R1, R2, R3 and X1-X6 are as defined within or a pharmaceutically acceptable salt, prodrug or solvate thereof, is described. Pharmaceutical compositions, methods and processes for preparation of compounds of formula (I) are also described.
    Type: Application
    Filed: September 9, 2002
    Publication date: March 24, 2005
    Inventors: Kevin Foote, Michael Block, Wayne Brailsford
  • Publication number: 20050041312
    Abstract: Spun-bond nonwoven material made of continuous filaments or fibers, whereby the continuous filaments or fibers are multi-component filaments, in particular bi-component filaments, with a low-melting component on the outer surface. The spun-bond nonwoven material is thermally bonded in a calender. The spun-bond nonwoven material has a mass per unit area of more than 40 g/m2.
    Type: Application
    Filed: July 30, 2004
    Publication date: February 24, 2005
    Inventors: Sebastian Sommer, Udo Schomer, Jorg Willinger, Michael Block
  • Patent number: 6652535
    Abstract: A distraction osteogenesis fixture to be anchored in a bone, including a lower anchor, a translational screw, and an upper anchor. At least a portion of the lower anchor is externally threaded. At least a portion of the lower anchor includes an anti-rotational feature. The lower anchor includes an internal passage. At least a portion of the internal passage is threaded. At least a portion of the translational screw is externally threaded such that the translational screw is receivable by the threaded internal passage of the lower anchor. The upper anchor includes an internal passage for receiving a portion of the lower anchor and has an anti-rotational feature for engaging the anti-rotational feature of the lower anchor. The internal passage of the upper anchor includes a surface for engaging the translational screw. At least a portion of the upper anchor is externally threaded.
    Type: Grant
    Filed: October 5, 2001
    Date of Patent: November 25, 2003
    Assignees: Nobel Biocare AB, Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Bjarne Kvarnstrom, Scott Lipka, Michael Luft, Michael Block
  • Publication number: 20020052608
    Abstract: A distraction osteogenesis fixture to be anchored in a bone, including a lower anchor, a translational screw, and an upper anchor. At least a portion of the lower anchor is externally threaded. At least a portion of the lower anchor includes an anti-rotational feature. The lower anchor includes an internal passage. At least a portion of the internal passage is threaded. At least a portion of the translational screw is externally threaded such that the translational screw is receivable by the threaded internal passage of the lower anchor. The upper anchor includes an internal passage for receiving a portion of the lower anchor and has an anti-rotational feature for engaging the anti-rotational feature of the lower anchor. The internal passage of the upper anchor includes a surface for engaging the translational screw. At least a portion of the upper anchor is externally threaded.
    Type: Application
    Filed: October 5, 2001
    Publication date: May 2, 2002
    Inventors: Bjarne Kvarnstrom, Scott Lipka, Michael Luft, Michael Block
  • Patent number: 6306143
    Abstract: A distraction osteogenesis fixture to be anchored in a bone, including a lower anchor, a translational screw, and an upper anchor. At least a portion of the lower anchor is externally threaded. At least a portion of the lower anchor includes an anti-rotational feature. The lower anchor includes an internal passage. At least a portion of the internal passage is threaded. At least a portion of the translational screw is externally threaded such that the translational screw is receivable by the threaded internal passage of the lower anchor. The upper anchor includes an internal passage for receiving a portion of the lower anchor and has an anti-rotational feature for engaging the anti-rotational feature of the lower anchor. The internal passage of the upper anchor includes a surface for engaging the translational screw. At least a portion of the upper anchor is externally threaded.
    Type: Grant
    Filed: January 19, 1999
    Date of Patent: October 23, 2001
    Assignee: Nobel Biocere AB
    Inventors: Bjarne Kvarnstrom, Scott Lipka, Michael Luft, Michael Block
  • Patent number: 6122535
    Abstract: A method of determining at least the concentration of a component from the intensity of electromagnetic waves with at least two selected wavelengths which are reflected by human tissue or transmitted through human tissue comprises firstly the step of converting the intensities of the received electromagnetic signals into at least one first and one second time-dependent electric signal. Then a time-discrete transformation of the first and of the second electric signal into the frequency domain is performed to determine first and second spectral values of the first and of the second signal. Complex combinatorial values are formed from said first and second spectral values and physiologically relevant combinatorial values are selected by evaluating the complex combinatorial values according to given criteria for the physiological relevance thereof. Finally, the concentration of the component is calculated by using the selected combinatorial values or by using the frequencywise-associated spectral values.
    Type: Grant
    Filed: March 10, 1998
    Date of Patent: September 19, 2000
    Assignee: Hewlett-Packard Company
    Inventors: Siegfried Kaestle, Hedwig Block, Michael Block